Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Price to Operating Profit (P/OP) 
since 2005

Microsoft Excel

Calculation

Boston Scientific Corp., P/OP, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Boston Scientific Corp. Annual Report.


Share Price Trend
The share price exhibited a general decline from 24 US$ in March 2006 to a low point of 6.09 US$ in February 2012. After this period, there was a noticeable recovery and consistent upward trend, reaching a peak of 47.18 US$ by February 2023. This trajectory indicates an initial phase of reduced market valuation followed by a steady regain in investor confidence and market performance.
Operating Profit Per Share (OPPS) Trend
Operating profit per share demonstrated significant volatility throughout the period analyzed. Starting at 1.18 US$ in 2006, it dropped sharply into negative values in subsequent years, hitting lows such as -2.85 US$ in 2013. Post-2013, OPPS showed improvement and moved into positive territory with some fluctuations, peaking at 1.15 US$ in 2023. The oscillating OPPS underscores periods of operating challenges and recovery phases within the company’s financial performance.
Price to Operating Profit Ratio (P/OP)
The P/OP ratio data is sporadic and not consistently available for all years, but notable points include a high value of 147.21 in 2014 and a general range decrease afterward. The ratio fluctuates significantly, reflecting volatility in operating profit relative to share price. Lower ratios observed in more recent years compared to earlier high points suggest relatively improved operating profitability or adjustments in share price valuation mechanisms aligning more closely with operational earnings.
Overall Financial Insights
The combined data reveals a company undergoing considerable operational challenges reflected by negative operating profits in multiple years up to around 2013. However, the sustained recovery in share price and stabilization of operating profits in positive territory post-2013 indicates a successful turnaround. The improvement in OPPS alongside rising share price supports enhanced operational effectiveness and growing market confidence. The P/OP's variability reflects changing investor sentiment linked to operating profit volatility but generally points to better alignment between earnings and market valuation in recent years.

Comparison to Competitors

Boston Scientific Corp., P/OP, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).